Anti-IL-6 Agents Suggested by SITC to Treat Patients with COVID-19
Researchers from SITC suggested the use of anti-IL-6 agents on a compassionate basis to treat hospitalized critically ill patients infected with COVID-19.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Hannah Slater Source Type: news
More News: Cancer & Oncology | COVID-19